Tenzing in its latest 8-K filing released an investor presentation highlighting Reviva Pharmaceuticals. A shareholder vote on the SPAC’s proposed merger with Reviva is set for Dec. 8. Read more.
Tenzing Releases Investor Presentation on Reviva
Related Posts
Khosla Ventures III Reclassifies Warrants, Hires New Accountant
Khosla going forward will classify its warrants as liabilities, aligning with the SEC's position announced in April.
Callodine Acquisition Launches $250M IPO
The SPAC will target businesses in the alternative asset management industry.
NextGen Acquisition II Prices $350M IPO
NextGen Acquisition II intends to focus on the industrial, technology, and healthcare sectors.
Every Member of Trump-Tied SPAC Board Hit with Federal Grand Jury Subpoena
The SPAC is under DOJ investigation and has also been subpoenaed by the SEC, which is demanding documents related to Digital World's due diligence on Trump Media & Technology Group.